Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q14765

Entry ID Method Resolution Chain Position Source
AF-Q14765-F1 Predicted AlphaFoldDB

413 variants for Q14765

Variant ID(s) Position Change Description Diseaes Association Provenance
CA62986893
rs906280014
2 S>A No ClinGen
TOPMed
gnomAD
rs778760914
CA2031003
7 V>A No ClinGen
ExAC
gnomAD
CA350002968
rs1363166746
9 Q>H No ClinGen
gnomAD
TCGA novel 15 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA350002877
rs1418758324
21 F>L No ClinGen
TOPMed
gnomAD
CA62986892
rs934903650
22 Y>C No ClinGen
Ensembl
rs1184514035
CA350002848
25 N>S No ClinGen
gnomAD
TCGA novel 27 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA62986891
rs867270496
31 R>Q No ClinGen
gnomAD
TCGA novel 32 H>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766134008
TCGA novel
CA2031000
32 H>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
rs1294017171
CA350002759
38 I>L No ClinGen
gnomAD
CA350002736
rs1207353579
41 Q>E No ClinGen
gnomAD
rs761161672
CA2030996
42 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA62986763
rs868421245
44 E>G No ClinGen
Ensembl
CA62986762
rs1003116465
46 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1381422972
CA350002680
47 S>A No ClinGen
TOPMed
TCGA novel 48 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1277833779
CA350002664
49 N>S No ClinGen
TOPMed
TCGA novel 51 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA350002642
rs1338661647
52 M>T No ClinGen
TOPMed
rs1308664127
CA350002632
53 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
COSM2157267
rs750095435
CA2030975
54 T>M Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA350002616
rs1320919269
56 L>F No ClinGen
gnomAD
CA350002606
rs1284825965
58 Q>E No ClinGen
gnomAD
rs990725052
CA62986760
58 Q>R No ClinGen
TOPMed
gnomAD
CA350002536
rs1444276228
67 Q>L No ClinGen
gnomAD
rs1468059700
CA350002518
70 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA350002517
rs751076320
COSM1288239
70 R>H Variant assessed as Somatic; 0.0 impact. autonomic_ganglia [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2030971
rs751076320
70 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA62986759
rs267599129
72 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs763673195
CA2030970
73 K>E No ClinGen
ExAC
gnomAD
TCGA novel 74 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1405872272
CA350002457
79 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA62986758
rs957846209
80 I>M No ClinGen
TOPMed
CA2030968
rs777271668
82 N>S No ClinGen
ExAC
gnomAD
rs1202108588
CA350002419
85 R>K No ClinGen
gnomAD
rs1462946559
CA350002414
86 I>L No ClinGen
gnomAD
rs202184860
CA2030966
87 R>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs773503051
CA2030965
91 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA349920612
rs1322131618
95 H>R No ClinGen
TOPMed
CA2030927
rs757999757
95 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2030926
rs752105122
99 M>V No ClinGen
ExAC
gnomAD
rs1267779076
CA349920575
100 H>L No ClinGen
gnomAD
rs1267779076
CA349920576
100 H>R No ClinGen
gnomAD
CA2030925
rs778453112
101 V>A No ClinGen
ExAC
gnomAD
rs1196585329
CA349920571
101 V>I No ClinGen
gnomAD
rs756625612
CA2030924
104 V>I No ClinGen
ExAC
gnomAD
rs1337434431
COSM1014172
CA349920537
107 N>H Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1337434431
CA349920535
107 N>Y No ClinGen
gnomAD
rs1287831571
CA349920510
110 R>K No ClinGen
TOPMed
VAR_036002 112 E>Q a breast cancer sample; somatic mutation [UniProt] No UniProt
TCGA novel 112 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2030920
VAR_020190
rs3024839
RCV000917583
115 I>V No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA2030919
rs372012413
118 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2030918
rs763055396
120 N>D No ClinGen
ExAC
gnomAD
CA349920391
rs1355355814
120 N>S No ClinGen
TOPMed
CA2030891
rs773188982
125 G>E No ClinGen
ExAC
gnomAD
CA349919687
rs1451770735
125 G>R No ClinGen
TOPMed
CA349919681
rs1305163633
126 P>S No ClinGen
TOPMed
CA2030889
rs140675301
RCV001326416
128 E>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1286913686
CA349919640
132 Q>R No ClinGen
TOPMed
gnomAD
TCGA novel 134 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 137 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA62697584
rs899829959
141 R>K No ClinGen
TOPMed
gnomAD
TCGA novel 141 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349919579
rs899829959
141 R>T No ClinGen
TOPMed
gnomAD
CA62697546
rs866566754
143 V>G No ClinGen
Ensembl
CA2030885
rs370819441
143 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370819441
CA2030886
143 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA349919558
rs757804856
144 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA349919550
rs1574130044
145 H>Q No ClinGen
Ensembl
CA349919544
rs1449256873
146 K>R No ClinGen
gnomAD
CA349919535
rs1340651373
147 V>G No ClinGen
gnomAD
rs747495835
CA2030883
148 A>P No ClinGen
ExAC
gnomAD
CA62697523
rs778170459
149 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA2030882
rs778170459
149 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs938231505
CA349919504
CA62697507
152 N>K No ClinGen
gnomAD
rs1574130004
CA349919500
153 S>N No ClinGen
Ensembl
CA2030881
rs758720903
154 V>M No ClinGen
ExAC
gnomAD
CA62697496
rs887698929
155 Q>K No ClinGen
TOPMed
gnomAD
CA2030868
rs376677137
156 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA62695636
rs906967754
156 M>V No ClinGen
TOPMed
rs372399682
CA62695630
157 T>A No ClinGen
ESP
TOPMed
gnomAD
rs775033600
CA2030867
161 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1559052991
CA349918799
162 K>N No ClinGen
Ensembl
rs1198723307
CA349918791
163 Y>H No ClinGen
TOPMed
gnomAD
rs1185323912
CA349918705
168 Q>E No ClinGen
TOPMed
CA349918674
rs1437812400
170 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1465000498
CA349918647
171 F>Y No ClinGen
gnomAD
rs778192508
CA2030863
174 R>G No ClinGen
ExAC
gnomAD
rs1047142705
CA62695560
175 Y>* No ClinGen
Ensembl
CA2030862
rs758709109
177 T>A No ClinGen
ExAC
gnomAD
rs1222308769
CA349918543
178 I>V No ClinGen
gnomAD
CA349918517
rs1393504305
179 Q>L No ClinGen
TOPMed
CA349918502
rs1364866424
180 T>S No ClinGen
gnomAD
CA2030860
rs779115246
181 M>I No ClinGen
ExAC
gnomAD
CA2030847
rs757114207
184 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs1482239088
CA349918199
184 S>N No ClinGen
gnomAD
CA349918176
rs1181051408
185 D>E No ClinGen
gnomAD
CA349918141
rs1242891280
187 N>I No ClinGen
gnomAD
CA349918137
rs1182171876
187 N>K No ClinGen
gnomAD
rs769304507
CA2030846
187 N>Y No ClinGen
ExAC
gnomAD
CA2030845
rs543324204
190 M>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 193 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1210136442
CA349918016
194 E>K No ClinGen
gnomAD
rs1315817328
CA349917975
196 L>S No ClinGen
gnomAD
rs1043051761
CA62693566
197 T>K No ClinGen
Ensembl
rs773619472
CA2030844
201 M>I No ClinGen
ExAC
gnomAD
CA2030843
rs144713478
204 S>R No ClinGen
1000Genomes
ExAC
gnomAD
CA349917785
rs1314061236
206 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1394096459
CA349917760
207 F>L No ClinGen
gnomAD
rs757165202
CA62692754
212 A>T No ClinGen
Ensembl
rs1007048272
CA62692749
212 A>V No ClinGen
TOPMed
gnomAD
rs145218540
CA2030821
214 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs778253892
CA2030820
217 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2030818
rs749622712
219 I>V No ClinGen
ExAC
rs780454944
CA2030817
221 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA349917309
rs1421052420
222 E>D No ClinGen
gnomAD
TCGA novel 224 D>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA62692727
rs994665092
225 L>P No ClinGen
TOPMed
rs770181391
CA2030816
227 M>T No ClinGen
ExAC
gnomAD
CA62692716
rs983517785
229 T>N No ClinGen
Ensembl
rs746059460
CA2030815
230 M>I No ClinGen
ExAC
gnomAD
CA2030814
rs781395541
231 L>I No ClinGen
ExAC
gnomAD
rs371181176
CA2030811
232 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2030812
rs746974489
232 I>T No ClinGen
ExAC
gnomAD
rs1282801873
CA349917173
232 I>V No ClinGen
TOPMed
CA62692662
rs1057075076
233 E>K No ClinGen
TOPMed
CA62692640
rs868401940
234 E>D No ClinGen
Ensembl
CA2030810
rs758217844
234 E>K No ClinGen
ExAC
gnomAD
CA349917058
rs61756200
240 R>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2030809
COSM3736230
rs61756200
240 R>Q skin [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA349917062
rs1280348818
240 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
RCV001344837
rs764990697
CA2030808
241 R>Q No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA349917054
rs1321732910
241 R>W No ClinGen
gnomAD
CA349917008
rs557179689
244 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA349917012
rs1574722792
244 I>N No ClinGen
Ensembl
CA2030806
rs201972198
245 A>S No ClinGen
1000Genomes
ExAC
gnomAD
CA2030805
rs201972198
245 A>T No ClinGen
1000Genomes
ExAC
gnomAD
CA2030804
rs760044145
245 A>V No ClinGen
ExAC
gnomAD
rs1574722755
CA349916996
246 C>R No ClinGen
Ensembl
rs927865408
CA62692588
246 C>Y No ClinGen
TOPMed
rs764656850
CA2030802
248 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 248 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2030800
rs776049747
252 H>R No ClinGen
ExAC
gnomAD
rs1376556409
CA349916950
252 H>Y No ClinGen
TOPMed
gnomAD
CA2030799
rs770273474
253 N>S No ClinGen
ExAC
gnomAD
CA2030796
rs771061948
256 D>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 257 Q>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1259826437
CA349916915
257 Q>R No ClinGen
gnomAD
CA349916898
rs1406155106
259 Q>H No ClinGen
TOPMed
CA62692557
rs113436186
260 N>D No ClinGen
Ensembl
rs747018092
CA62692556
260 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA62691562
rs779542390
265 L>S No ClinGen
gnomAD
TCGA novel 267 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2030778
rs35279173
269 L>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 269 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 270 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs571829920
CA62691535
271 Q>H No ClinGen
1000Genomes
ExAC
gnomAD
CA2030774
rs748082505
273 R>G No ClinGen
ExAC
gnomAD
rs778762924
CA2030773
273 R>K No ClinGen
ExAC
gnomAD
TCGA novel 277 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1309147163
CA349915982
277 E>Q No ClinGen
TOPMed
CA2030770
rs142125913
280 E>K No ClinGen
ESP
ExAC
gnomAD
rs750090759
CA2030768
284 T>I No ClinGen
ExAC
gnomAD
rs1224813392
CA349915925
285 K>T No ClinGen
TOPMed
CA349915913
rs780920887
CA2030767
286 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
rs1292597944
CA349915916
286 M>T No ClinGen
TOPMed
CA349915911
rs1559049854
287 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA62691483
rs1045189793
290 G>C No ClinGen
TOPMed
rs1045189793
CA349915889
290 G>S No ClinGen
TOPMed
CA62691474
rs949674648
293 I>F No ClinGen
Ensembl
CA2030764
rs765796756
294 P>L No ClinGen
ExAC
gnomAD
rs760055169
CA2030763
295 M>K No ClinGen
ExAC
gnomAD
rs754199351
CA2030762
297 R>G No ClinGen
ExAC
gnomAD
CA2030761
rs200982266
298 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1262522306
CA349915778
300 M>T No ClinGen
gnomAD
rs1214589655
CA349915752
301 L>I No ClinGen
gnomAD
CA349915730
rs1356413880
302 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1287387742
CA349915677
304 V>A No ClinGen
gnomAD
TCGA novel 305 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1406319643
CA349915643
306 F>C No ClinGen
gnomAD
TCGA novel 306 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349915646
rs1406319643
306 F>S No ClinGen
gnomAD
rs548245892
CA2030759
307 L>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs761830960
CA2030757
308 I>S No ClinGen
ExAC
gnomAD
rs772150342
CA2030758
308 I>V No ClinGen
ExAC
gnomAD
rs1355742046
CA349915585
309 Y>C No ClinGen
gnomAD
rs1296987566
CA349915553
310 N>S No ClinGen
gnomAD
CA2030754
rs749227253
311 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs749227253
CA2030755
311 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs779772586
CA349915516
312 F>L No ClinGen
ExAC
gnomAD
rs779772586
CA2030753
312 F>V No ClinGen
ExAC
gnomAD
CA349915474
COSM1014169
rs1574720694
313 K>N endometrium [Cosmic] No ClinGen
cosmic curated
Ensembl
CA2030738
COSM1014168
rs143642103
320 R>Q endometrium [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1405758156
CA349915218
323 C>S No ClinGen
gnomAD
rs1399751509
CA349915212
323 C>Y No ClinGen
gnomAD
CA2030735
rs769491603
324 M>I No ClinGen
ExAC
gnomAD
CA2030736
rs775435376
324 M>V No ClinGen
ExAC
gnomAD
rs1424401939
CA349915174
325 P>L No ClinGen
gnomAD
CA62690949
rs989036709
326 T>A No ClinGen
Ensembl
CA349915087
rs1248978329
331 P>Q No ClinGen
gnomAD
CA2030732
rs770753645
336 T>S No ClinGen
ExAC
gnomAD
CA62690937
COSM1404137
rs941296401
340 F>L large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs746642521
CA349914955
341 T>A No ClinGen
ExAC
gnomAD
CA2030731
rs746642521
341 T>S No ClinGen
ExAC
gnomAD
CA2030730
rs777211622
342 V>A No ClinGen
ExAC
gnomAD
rs1274749529
CA349914932
343 K>Q No ClinGen
TOPMed
gnomAD
CA2030729
rs757857474
344 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA349914319
rs1374240747
348 I>T No ClinGen
TOPMed
gnomAD
rs1302479885
CA349914315
349 K>Q No ClinGen
gnomAD
CA2030701
rs757553644
357 V>I No ClinGen
ExAC
gnomAD
rs751746803
CA2030700
361 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1160760350
CA349914121
363 I>F No ClinGen
gnomAD
rs764332457
CA2030699
363 I>T No ClinGen
ExAC
gnomAD
rs1357283354
CA349914025
366 N>K No ClinGen
Ensembl
CA2030681
rs777972042
367 V>L No ClinGen
ExAC
gnomAD
rs1459780971
CA349913964
372 N>S No ClinGen
TOPMed
gnomAD
rs768169551
CA2030669
373 R>* No ClinGen
ExAC
gnomAD
CA349913959
rs1205627852
373 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA62688623
rs750700455
375 F>L No ClinGen
Ensembl
rs762403752
CA2030667
376 V>A No ClinGen
ExAC
gnomAD
rs1559047895
CA349913928
376 V>I No ClinGen
Ensembl
CA349913873
rs1447127105
381 N>H No ClinGen
TOPMed
rs771471597
CA2030665
382 V>A No ClinGen
ExAC
gnomAD
rs1194733770
CA349913859
382 V>L No ClinGen
gnomAD
rs376043190
COSM4133344
CA62688587
385 M>I thyroid [Cosmic] No ClinGen
cosmic curated
ESP
TOPMed
gnomAD
TCGA novel 385 M>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349913816
rs1266601736
385 M>T No ClinGen
gnomAD
rs1273647880
CA349913793
COSM476675
387 I>T kidney [Cosmic] No ClinGen
cosmic curated
gnomAD
CA2030664
rs368876096
387 I>V No ClinGen
ExAC
gnomAD
CA349913730
rs1198228238
392 N>S No ClinGen
gnomAD
CA2030663
rs199633613
393 G>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1228274775
CA349913668
397 V>A No ClinGen
gnomAD
rs1330972500
CA349913656
398 E>G No ClinGen
gnomAD
CA349913628
rs1040221969
400 R>L No ClinGen
TOPMed
gnomAD
CA62688574
rs1040221969
400 R>Q No ClinGen
TOPMed
gnomAD
CA2030645
rs775033790
403 Q>L No ClinGen
ExAC
gnomAD
rs200636478
CA2030643
404 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs764645584
CA2030644
404 P>S No ClinGen
ExAC
gnomAD
CA349912885
rs1308921436
407 M>L No ClinGen
gnomAD
TCGA novel 408 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349912867
rs1164716591
409 S>C No ClinGen
TOPMed
rs1390679318
CA349912862
410 S>G No ClinGen
TOPMed
rs772506095
CA2030641
413 G>A No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 414 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1353266416
CA349911602
419 C>Y No ClinGen
TOPMed
gnomAD
CA349911524
rs1218971959
425 E>D No ClinGen
TOPMed
CA62678786
rs868583326
425 E>G No ClinGen
Ensembl
rs763858532
CA2030629
429 I>T No ClinGen
ExAC
gnomAD
CA62678783
rs968005627
429 I>V No ClinGen
TOPMed
CA2030628
rs758109437
COSM1404135
430 T>M Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA349911454
rs758109437
430 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs1414652458
CA349911342
436 C>Y No ClinGen
TOPMed
CA349911310
rs1356001770
438 Y>C No ClinGen
TOPMed
CA349911269
rs1430232250
442 I>T No ClinGen
TOPMed
rs764815073
CA2030626
442 I>V No ClinGen
ExAC
gnomAD
CA62678745
rs866679884
445 E>G No ClinGen
Ensembl
rs1297504781
CA349911231
445 E>K No ClinGen
gnomAD
CA2030605
rs141331848
446 T>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs530278225
CA62677848
447 S>R No ClinGen
TOPMed
rs544508292
CA2030603
450 P>A No ClinGen
1000Genomes
ExAC
gnomAD
CA349910964
rs1198519440
461 P>S No ClinGen
gnomAD
CA2030601
rs762476453
464 W>* No ClinGen
ExAC
gnomAD
CA349910889
rs1335109291
467 I>V No ClinGen
gnomAD
CA349910839
rs1380306157
470 Y>C No ClinGen
TOPMed
CA349910829
rs1256812727
471 N>H No ClinGen
TOPMed
gnomAD
CA349910816
rs1325742273
472 V>M No ClinGen
TOPMed
CA2030598
rs146386562
475 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2030597
rs146386562
475 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA349910763
rs1327713544
476 D>G No ClinGen
gnomAD
COSM1014165
CA2030595
rs759785386
476 D>N endometrium skin Variant assessed as Somatic; 4.62e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA62677806
rs759785386
476 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs765625619
CA2030578
479 N>H No ClinGen
ExAC
gnomAD
CA349910107
rs1376354446
479 N>S No ClinGen
gnomAD
rs769270663
CA349910094
481 V>F No ClinGen
ExAC
gnomAD
CA2030576
rs769270663
481 V>I No ClinGen
ExAC
gnomAD
rs1355167764
CA349910059
484 N>K No ClinGen
gnomAD
rs1333640618
CA349910057
485 N>D No ClinGen
gnomAD
CA2030575
rs771017653
485 N>T No ClinGen
ExAC
CA349910024
rs1439466042
488 P>S No ClinGen
gnomAD
rs1378912299
CA349910001
490 T>K No ClinGen
gnomAD
rs149621054
CA2030570
491 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM3962104
CA349909975
rs1389143163
492 S>N lung [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1416951111
CA349909904
497 V>A No ClinGen
TOPMed
gnomAD
CA62676058
rs1010398726
497 V>M No ClinGen
Ensembl
rs1205460471
CA349909898
498 M>L No ClinGen
TOPMed
CA349909890
rs1484618473
498 M>T No ClinGen
gnomAD
CA349909872
rs1282396345
499 S>N Variant assessed as Somatic; 4.619e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1256467133
CA349909881
499 S>R No ClinGen
TOPMed
TCGA novel 502 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349909800
rs1235014939
504 S>L No ClinGen
TOPMed
gnomAD
CA349909770
rs1477938637
506 V>A No ClinGen
TOPMed
CA2030565
rs749994944
506 V>I No ClinGen
ExAC
gnomAD
CA349909749
rs1192576162
507 G>V No ClinGen
TOPMed
rs780829180
CA2030564
508 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2030563
rs376947712
508 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
rs780829180
CA349909746
COSM1014164
508 R>S endometrium Variant assessed as Somatic; 4.619e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs147007636
CA2030562
513 D>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs755317297
CA2030561
517 M>L No ClinGen
ExAC
gnomAD
CA349909545
rs1314004125
517 M>R No ClinGen
gnomAD
rs755317297
CA2030560
517 M>V No ClinGen
ExAC
gnomAD
CA62676010
rs1054195155
520 E>Q No ClinGen
Ensembl
rs1343769850
CA349909442
523 T>S No ClinGen
gnomAD
rs1259577677
CA349908575
526 S>C No ClinGen
gnomAD
CA349908576
rs1259577677
526 S>Y No ClinGen
gnomAD
CA349908556
rs1486064143
529 S>G No ClinGen
gnomAD
rs760335389
CA2030538
529 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA349908551
rs1365762129
529 S>R No ClinGen
gnomAD
rs1212020747
CA349908545
530 D>V No ClinGen
TOPMed
gnomAD
rs147850919
CA349908530
532 H>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2030536
rs767596903
533 L>F No ClinGen
ExAC
gnomAD
rs1218110907
CA349908509
535 W>* No ClinGen
gnomAD
CA349908516
rs1228572445
535 W>R No ClinGen
TOPMed
CA2030535
rs761904937
536 A>T No ClinGen
ExAC
gnomAD
rs774187563
CA2030534
539 C>Y No ClinGen
ExAC
gnomAD
TCGA novel 541 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs765178000
CA2030512
542 H>Y No ClinGen
ExAC
gnomAD
COSM107095
rs144091208
CA62674451
547 S>L Variant assessed as Somatic; impact. skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs998455229
CA62674453
547 S>P No ClinGen
TOPMed
gnomAD
rs373191999
CA62674443
550 F>L No ClinGen
ESP
TOPMed
rs776531286
CA2030510
551 W>* No ClinGen
ExAC
gnomAD
TCGA novel 551 W>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349908361
rs1252710156
555 E>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1196480246
CA349908350
556 A>G No ClinGen
gnomAD
CA349908327
rs1485599626
560 L>I No ClinGen
gnomAD
TCGA novel 564 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760189410
CA2030508
566 L>R No ClinGen
ExAC
gnomAD
CA62674438
rs866115797
567 P>S No ClinGen
Ensembl
rs930222758
CA62674343
573 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA62674336
rs868099569
575 M>I No ClinGen
Ensembl
CA349908169
rs1350322245
581 E>K No ClinGen
TOPMed
COSM1404134
CA62674312
rs779069171
584 R>L large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs779069171
CA2030487
584 R>Q No ClinGen
ExAC
gnomAD
VAR_047939
CA2030488
rs3024933
584 R>W No ClinGen
UniProt
1000Genomes
ExAC
dbSNP
gnomAD
CA62674280
rs199609035
586 L>V No ClinGen
Ensembl
CA2030486
rs761281261
591 M>I No ClinGen
ExAC
gnomAD
CA349908100
rs1574692524
591 M>K No ClinGen
Ensembl
CA2030485
rs773810325
592 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs1317305981
CA349908081
594 T>N No ClinGen
gnomAD
TCGA novel 596 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770306554
CA2030484
597 L>S No ClinGen
ExAC
TOPMed
gnomAD
rs201150110
CA2030483
602 S>R No ClinGen
1000Genomes
ExAC
gnomAD
rs771192197
CA349907945
605 G>* No ClinGen
ExAC
TOPMed
gnomAD
rs771192197
CA2030481
605 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 615 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA349907796
rs1242585998
616 E>A No ClinGen
TOPMed
rs777832373
CA2030479
617 S>T No ClinGen
ExAC
gnomAD
CA2030462
rs776987023
618 G>A No ClinGen
ExAC
gnomAD
TCGA novel 618 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs962047809
CA349907694
619 E>D No ClinGen
TOPMed
gnomAD
CA349907683
rs1215254020
620 V>A No ClinGen
gnomAD
CA349907618
rs1271723949
625 V>I No ClinGen
gnomAD
rs1212691239
CA349907605
626 E>Q No ClinGen
gnomAD
CA2030459
rs149089413
632 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA349907516
rs1226293129
632 R>W No ClinGen
TOPMed
CA2030457
rs369720896
638 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs755096256
CA2030455
639 A>S No ClinGen
ExAC
gnomAD
rs755096256
CA349907431
639 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA349907371
rs1481899244
643 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1193226178
CA349907306
648 I>V No ClinGen
gnomAD
CA62673974
rs980303842
649 M>V No ClinGen
TOPMed
gnomAD
CA349907265
rs1412086117
651 E>G No ClinGen
gnomAD
rs1412086117
RCV001341751
651 E>V No ClinVar
dbSNP
rs749296968
CA2030454
653 I>M No ClinGen
ExAC
gnomAD
CA349907252
rs1420870478
653 I>V No ClinGen
TOPMed
gnomAD
CA2030452
rs756037985
657 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2030448
rs751205891
668 D>G No ClinGen
ExAC
gnomAD
CA2030446
rs762343259
672 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs777230968
CA2030445
673 K>R No ClinGen
ExAC
gnomAD
CA2030443
rs761189841
677 S>C No ClinGen
ExAC
gnomAD
CA2030444
rs766821566
677 S>T No ClinGen
ExAC
gnomAD
rs1277796577
CA349906985
679 P>L No ClinGen
gnomAD
CA2030442
rs368928990
680 C>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA349906979
rs1444471536
680 C>G No ClinGen
TOPMed
gnomAD
rs1444471536
CA349906981
680 C>R No ClinGen
TOPMed
gnomAD
rs1312794455
CA349906966
681 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA349906719
rs1412013869
684 R>T No ClinGen
gnomAD
CA349906714
rs1163611406
685 P>A No ClinGen
gnomAD
TCGA novel 687 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761155615
CA2030417
688 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA2030416
rs371989874
688 R>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs768045385
CA2030415
688 R>S No ClinGen
ExAC
gnomAD
CA349906691
rs1574690038
689 G>S No ClinGen
Ensembl
rs774816816
CA2030413
690 D>A No ClinGen
ExAC
gnomAD
rs774816816
CA2030414
690 D>G No ClinGen
ExAC
gnomAD
rs915485744
CA62672957
690 D>H No ClinGen
TOPMed
gnomAD
rs915485744
CA349906685
690 D>N No ClinGen
TOPMed
gnomAD
rs1330106664
CA349906672
692 G>S No ClinGen
gnomAD
TCGA novel 693 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 695 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768782205
CA2030412
697 V>F No ClinGen
ExAC
gnomAD
CA349906449
rs1449832035
705 R>* No ClinGen
gnomAD
CA2030388
rs370218298
705 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA62672765
rs111535990
707 D>G No ClinGen
Ensembl
CA2030387
rs770874469
709 T>A No ClinGen
ExAC
gnomAD
CA349906397
rs746885035
709 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs746885035
CA2030386
709 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA349906389
rs1195317909
710 E>G No ClinGen
gnomAD
rs752431273
CA62672750
712 H>R No ClinGen
Ensembl
CA2030385
rs772952207
712 H>Y No ClinGen
ExAC
gnomAD
rs1206579181
CA349906356
715 S>L No ClinGen
gnomAD
rs771889653
CA2030384
726 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1390304797
CA349906167
730 E>Q No ClinGen
gnomAD
CA349906132
rs1430375004
735 T>A No ClinGen
TOPMed
gnomAD
rs908276985
CA62672714
736 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA349906112
rs1450518281
738 E>A No ClinGen
TOPMed
TCGA novel 742 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM3425884
CA62704387
rs773968889
744 P>H large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs773968889
CA2030364
744 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1574687918
CA349931470
744 P>S No ClinGen
Ensembl
rs768437698
CA2030363
747 A>V No ClinGen
ExAC
gnomAD

2 associated diseases with Q14765

[MIM: 612253]: Systemic lupus erythematosus 11 (SLEB11)

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:17804842, ECO:0000269|PubMed:19109131}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

[MIM: 180300]: Rheumatoid arthritis (RA)

An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. {ECO:0000269|PubMed:17804842}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

Without disease ID
  • A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:17804842, ECO:0000269|PubMed:19109131}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.
  • An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. {ECO:0000269|PubMed:17804842}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

1 regional properties for Q14765

Type Name Position InterPro Accession
domain Luciferase-like domain 1 - 332 IPR011251

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Translocated into the nucleus in response to phosphorylation
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
RNA polymerase II transcription regulator complex A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.

4 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
identical protein binding Binding to an identical protein or proteins.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.

7 GO annotations of biological process

Name Definition
cytokine-mediated signaling pathway The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
defense response Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
receptor signaling pathway via JAK-STAT Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The receptor signaling pathway via JAK-STAT begins with activation of a receptor and proceeeds through STAT protein activation by members of the JAK family of tyrosine kinases. STAT proteins dimerize and subsequently translocate to the nucleus. The pathway ends with regulation of target gene expression by STAT proteins.
regulation of cell population proliferation Any process that modulates the frequency, rate or extent of cell proliferation.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
response to peptide hormone Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P61635 STAT3 Signal transducer and activator of transcription 3 Bos taurus (Bovine) PR
Q6DV79 STAT3 Signal transducer and activator of transcription 3 Gallus gallus (Chicken) PR
P51692 STAT5B Signal transducer and activator of transcription 5B Homo sapiens (Human) PR
P52630 STAT2 Signal transducer and activator of transcription 2 Homo sapiens (Human) PR
P40763 STAT3 Signal transducer and activator of transcription 3 Homo sapiens (Human) PR
P42224 STAT1 Signal transducer and activator of transcription 1-alpha/beta Homo sapiens (Human) PR
P42229 STAT5A Signal transducer and activator of transcription 5A Homo sapiens (Human) PR
P42230 Stat5a Signal transducer and activator of transcription 5A Mus musculus (Mouse) PR
P42225 Stat1 Signal transducer and activator of transcription 1 Mus musculus (Mouse) PR
Q9WVL2 Stat2 Signal transducer and activator of transcription 2 Mus musculus (Mouse) PR
P42227 Stat3 Signal transducer and activator of transcription 3 Mus musculus (Mouse) PR
P42228 Stat4 Signal transducer and activator of transcription 4 Mus musculus (Mouse) PR
Q19S50 STAT3 Signal transducer and activator of transcription 3 Sus scrofa (Pig) PR
P52631 Stat3 Signal transducer and activator of transcription 3 Rattus norvegicus (Rat) PR
Q9NAD6 sta-1 Signal transducer and activator of transcription 1 Caenorhabditis elegans PR
10 20 30 40 50 60
MSQWNQVQQL EIKFLEQVDQ FYDDNFPMEI RHLLAQWIEN QDWEAASNNE TMATILLQNL
70 80 90 100 110 120
LIQLDEQLGR VSKEKNLLLI HNLKRIRKVL QGKFHGNPMH VAVVISNCLR EERRILAAAN
130 140 150 160 170 180
MPVQGPLEKS LQSSSVSERQ RNVEHKVAAI KNSVQMTEQD TKYLEDLQDE FDYRYKTIQT
190 200 210 220 230 240
MDQSDKNSAM VNQEVLTLQE MLNSLDFKRK EALSKMTQII HETDLLMNTM LIEELQDWKR
250 260 270 280 290 300
RQQIACIGGP LHNGLDQLQN CFTLLAESLF QLRRQLEKLE EQSTKMTYEG DPIPMQRTHM
310 320 330 340 350 360
LERVTFLIYN LFKNSFVVER QPCMPTHPQR PLVLKTLIQF TVKLRLLIKL PELNYQVKVK
370 380 390 400 410 420
ASIDKNVSTL SNRRFVLCGT NVKAMSIEES SNGSLSVEFR HLQPKEMKSS AGGKGNEGCH
430 440 450 460 470 480
MVTEELHSIT FETQICLYGL TIDLETSSLP VVMISNVSQL PNAWASIIWY NVSTNDSQNL
490 500 510 520 530 540
VFFNNPPPAT LSQLLEVMSW QFSSYVGRGL NSDQLHMLAE KLTVQSSYSD GHLTWAKFCK
550 560 570 580 590 600
EHLPGKSFTF WTWLEAILDL IKKHILPLWI DGYVMGFVSK EKERLLLKDK MPGTFLLRFS
610 620 630 640 650 660
ESHLGGITFT WVDHSESGEV RFHSVEPYNK GRLSALPFAD ILRDYKVIMA ENIPENPLKY
670 680 690 700 710 720
LYPDIPKDKA FGKHYSSQPC EVSRPTERGD KGYVPSVFIP ISTIRSDSTE PHSPSDLLPM
730 740
SPSVYAVLRE NLSPTTIETA MKSPYSAE